Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

This publication has 83 references indexed in Scilit:

• Amisulpride has a superior benefit/risk profile to haloperidol in schizophrenia: results of a multicentre, double-blind study (the Amisulpride Study Group^*
  European Psychiatry, 2000
• Cognitive and behavioural functioning in men with schizophrenia both before and shortly after first admission to hospital
  The British Journal of Psychiatry, 2000
• Clozapine versus typical neuroleptic medication for schizophrenia
  Published by Wiley ,1999
• The Role of Serotonin in Antipsychotic Drug Action
  Neuropsychopharmacology, 1999
• Special Feature: Childhood Personality Characteristics of Schizophrenia: Manifestations of, or Risk Factors for, the Disorder?
  Journal of Personality Disorders, 1998
• D₂-Dopamine Receptor Occupancy measured by IBZM-SPECT in Relation to Extrapyramidal Side Effects
  Pharmacopsychiatry, 1998
• Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist
  Trends in Pharmacological Sciences, 1997
• Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs
  Trends in Neurosciences, 1997
• Amisulpride
  CNS Drugs, 1996
• Overcoming the neuroleptic‐induced deficit syndrome: clinical observations with remoxipride
  Acta Psychiatrica Scandinavica, 1994